Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Queen’s University Researchers Pioneer Food Safety Testing

30.10.2006
With international demand amongst consumers and regulators for improved food safety never greater, a research project at Queen’s University Belfast, led by Professor Chris Elliott, and using the latest techniques in Nanotechnology, has resulted in the development of a new biosensor test kit capable of detecting an entire family of toxic drugs in foods.

The drug group, known as Nitroimidazoles, was once widely used in veterinary medicine to treat animal disease such as anaerobic bacterial and parasitic infections, but concerns over the safety of the drugs led to them being banned for use in animal production. However, due to their effectiveness in the treatment of certain diseases and the difficultly in detecting the misuse of the drugs, it has been alleged that widespread use of these drugs in some parts of the world still persists. The presence or absence of such drug residues in food commodities has major implications in respect to both food safety and international trade.

Funded by the Invest Northern Ireland ‘Proof of Concept’ programme, Professor Elliott, Head of the Food Safety Research Group at Queen’s, has now used the latest techniques in Nanotechnology to provide an innovative food-testing kit for such residues that is exceptionally rapid and reliable in comparison to the complex, costly and time-consuming monitoring systems currently available.

Many or even most of the food ingredients eaten every day contain nanoscale particles and naturally occurring nanoscale ingredients and the value of nanotechnology to the food industry has been estimated at £220 million in 2006. That figure is expected to grow to over £3 billion by 2012.

Having developed the reagents involved and optimised an analytical procedure using an optical biosensor to detect the presence of the drugs in foods, Professor Elliott and his team then sent a prototype test kit to regulatory laboratories around the world. The results of this multi-national validation exercise proved the kit could actually detect the compounds involved to the low parts per billion (ppb) levels required. This in turn, generated high levels of interest from the major regulatory bodies involved and several commercial entities, before Xenosense Ltd, a Northern Ireland based biosensor kit manufacturer agreed to commercialise the product.

Speaking about the revolutionary new kit and the commercialisation process, Professor Elliott said: “It is projects like this that illustrate the importance of the viable research being performed at Queen’s Institute of Agri-Food and Land Use, in addressing current food safety issues and in being able to transfer that knowledge through to the advantage of local industry.

“To have a company such as Xenosense Ltd, a Northern Ireland based biosensor kit manufacturer and one of our spin out companies from Queen’s through the QUBIS operation, agree to commercialise the method and offer the product to both the global market of regulatory laboratories and the Agri-Food Industry, is proof positive of the value of our work.

“The official launch of the new product is planned for later this year and we are delighted that with the help of Invest NI, we have taken a locally funded research programme and converted it into a commercially viable end product which will make a real difference to people’s lives.”

John Thompson, Director of Innovation, Research and Technology at Invest NI added: “Proof of Concept has proven itself to be a vital source of assistance for innovative research projects undertaken at both Queen’s University and the University of Ulster.

“By supporting the pre-commercialisation of leading-edge technologies emerging from Northern Ireland’s universities, Proof of Concept can support researchers as they bring inventions and ideas into the global marketplace – adding wealth to our economy and further reinforcing Northern Ireland as a world class research and development hub.”

Lisa Mitchell | alfa
Further information:
http://www.qub.ac.uk

More articles from Health and Medicine:

nachricht New antibody analysis accelerates rational vaccine design
09.08.2018 | Scripps Research Institute

nachricht Distrust of power influences choice of medical procedures
01.08.2018 | Johannes Gutenberg-Universität Mainz

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

Im Focus: Lining up surprising behaviors of superconductor with one of the world's strongest magnets

Scientists have discovered that the electrical resistance of a copper-oxide compound depends on the magnetic field in a very unusual way -- a finding that could help direct the search for materials that can perfectly conduct electricity at room temperatur

What happens when really powerful magnets--capable of producing magnetic fields nearly two million times stronger than Earth's--are applied to materials that...

Im Focus: World record: Fastest 3-D tomographic images at BESSY II

The quality of materials often depends on the manufacturing process. In casting and welding, for example, the rate at which melts solidify and the resulting microstructure of the alloy is important. With metallic foams as well, it depends on exactly how the foaming process takes place. To understand these processes fully requires fast sensing capability. The fastest 3D tomographic images to date have now been achieved at the BESSY II X-ray source operated by the Helmholtz-Zentrum Berlin.

Dr. Francisco Garcia-Moreno and his team have designed a turntable that rotates ultra-stably about its axis at a constant rotational speed. This really depends...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

2018 Work Research Conference

25.07.2018 | Event News

 
Latest News

'Building up' stretchable electronics to be as multipurpose as your smartphone

14.08.2018 | Information Technology

During HIV infection, antibody can block B cells from fighting pathogens

14.08.2018 | Life Sciences

First study on physical properties of giant cancer cells may inform new treatments

14.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>